Adc Therapeutics

Developer of antibody-drug conjugates for the treatment of cancer indications

placeEpalinges, Vaud, Switzerland calendar_todayFounded 2011 groups50 employees language adctherapeutics.com

Registered entities

Social engagement

Social engagement: 23.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Auven Therapeutics, MedImmune, AstraZeneca; 1 has since exited.

Investor typeCountShare
Venture capital857%
Private equity214%
Bank & private debt17%
Other / undisclosed321%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

2 Feb 2026 · Medical Science Liaison (Northeast) · New Boston

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Milestone
regulatory
28 May 2026
Recognition
26 May 2026
Recognition
Coming soon